ClinicalTrials.Veeva

Menu

Normal Values of High Frequency ECG (HyperQ™) in Apparently Healthy Individuals and in Young and Masters Athletes

B

BSP Biological Signal Processing

Status

Unknown

Conditions

Healthy
Obesity
Asymptomatic

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

The main objective of this study is to investigate depolarization characteristics represented by changes in HyperQ in asymptomatic, apparently healthy athletic and non-athletic individuals. We also aim to examine a subgroup of obese and non-obese subjects. The goal of the study is to establish normal HyperQ values in these populations and compare HyperQ values of age-matched athletic vs. non-athletic individuals of similar health status.

Enrollment

300 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • An asymptomatic, apparently healthy patient performing a maximal exercise stress test

Exclusion criteria

  • Contraindications for an exercise test
  • Wolff-Parkinson-White (pre-excitation) syndrome
  • Atrial Fibrillation or significant ventricular arrhythmia
  • Treatment with Digoxin
  • Pacemaker
  • Pregnancy or suspected pregnancy
  • QRS duration>120ms or other conduction delays

Trial contacts and locations

1

Loading...

Central trial contact

Eyal Shargal, PhD; • Irena Imanuel, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems